Saba Capital Management, L.P. sold HQL
February 12, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 36,536 shares of Abrdn Life Sciences Investors at $13.75 per share, a transaction worth $502.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
36,536
Price
$13.75
Total value
$502.4K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 12, 2025
Filing dateFebruary 13, 2025
Shares owned after3,276,181
OwnershipIndirect
10b5-1 planNo
AmendedNo